We’re pleased to announce a significant company milestone as Ireland just became the 13th country with our medical cannabis products. https://t.co/X22frtHng2
— Tilray (@tilray) July 11, 2019
The Tilray products successfully imported will be made available to qualified patients through the Access Programme once distribution approvals are provided by local regulators.
This will allow patients in Ireland access to a locally maintained supply of GMP-certified products, which they can receive in a reasonable time-frame.
Authorised patients are expected to be able to access Tilray medical cannabis products through the Irish community pharmacy network in the second half of the year.
Catherine Jacobson, Tilray’s Vice President of Medical and Regulatory Affairs, said:
“This development in Ireland represents an exciting turning point for patients. We’re proud to have the opportunity to provide patients in Ireland with access to Tilray’s standardized GMP-certified medical cannabis products, and we’re thrilled to see an increasing number of countries improve access to medical cannabis.”